• Home
  • BVR and IP Valuation
  • IP Value Products
  • Your Account
    • Checkout
  • ktMine
  • Free IP Value Wire
  • Contact BVR
RSS Subscribe RSS

BVR's IP Management & Valuation Wire

News and best practices on valuing intellectual property

U.S. Supreme Court decides for Monsanto and its patent on weed-killer resistant soybean seeds

Written by Randy on May 15, 2013 - 0 Comments
Categories: case law analysis, commercial litigation, IP valuation research, licensing, Patent Litigation, Patents

In a unanimous ruling on May 13, 2013, in BOWMAN v. MONSANTO CO. ET AL., the Supreme Court supported the patent protection afforded Monsanto’s weed-killer-resistant soybeans by saying the principle of patent exhaustion doesn’t permit a farmer to reproduce patented seeds through planting and harvesting without the patent holder’s permission. Bookmark on DeliciousDigg this postRecommend [...]

Read more »

Share your thoughts...

US patent court says an abstract idea is not patentable simply because it is tied to a computer system

Written by Randy on May 13, 2013 - 1 Comment
Categories: case law analysis, commercial litigation, IP valuation research, Patent Litigation, Patents, software patent

In CLS Bank v. Alice Corporation, 11-1301, the U.S. Court of Appeals for the Federal Circuit (Washington) ruled on May 10, 2013, that patents held by an Australian electronic financial firm (Alice Corporation) are not valid because the claims are too abstract to qualify for such intellectual property protection. Alice had argued the patents were [...]

Read more »

1 Comment

U.S. Chamber of Commerce responds to India’s denial of the Glivec patent

Written by Randy on May 7, 2013 - 0 Comments
Categories: case law analysis, commercial litigation, IP valuation research, Patent Litigation, Patents

On April 1, 2013, the Supreme Court of India finalized the denial of Novartis’ patent on its cancer drug Glivec, despite the fact the patent is recognized in 40 countries. The lay press and public interest groups have centered the debate on pricing. The Indian Pharmaceutical Alliance disagrees. Bookmark on DeliciousDigg this postRecommend on Facebookshare [...]

Read more »

Share your thoughts...

District Court Judge offers specific amounts that fit the terms criteria for “fair, reasonable and non-discriminatory”

Written by Randy on May 3, 2013 - 0 Comments
Categories: case law analysis, commercial litigation, damages, IP valuation research, IP value comparables & research, licensing, Patent Litigation, royalties-reasonable, royalty, software patent

Standard-setting organizations establish rules that govern the ownership of IP rights that apply to the standards they adopt. Companies that help establish the criteria gain an advantage in having their technology included in standards; therefore, one rule commonly adopted is that any patent that applies to a standard can only be licensed on “fair, reasonable, and non-discriminatory [...]

Read more »

Share your thoughts...

Apple SEC filing reveals strategy with respect to VirnetX ruling

Written by Randy on April 30, 2013 - 0 Comments
Categories: damages, damages and lost profits valuations, IP strategy, IP valuation research, Patent Litigation, Patents

On August 11, 2010, VirnetX, Inc. filed an action against Apple alleging that certain of its products infringed on four patents relating to network communications technology. On November 6, 2012, a jury returned a verdict for VirnetX, and awarded damages of $368 million. Bookmark on DeliciousDigg this postRecommend on Facebookshare via RedditShare with StumblersTweet about [...]

Read more »

Share your thoughts...

Still one more judge admonishes experts in damages cases to tie facts of the case to the theory used

Written by Randy on April 23, 2013 - 0 Comments
Categories: case law analysis, damages, Daubert hearing, expert witness, IP valuation research, Patent Litigation

Ever since Uniloc’s rejection of the 15%-of-gross-profit rule-of-thumb for determining damages, experts have been attempting to combine other theories with Georgia Pacific factors.  Another attempt to use the Nash Bargaining Solution (NBS) to determine a reasonable royalty rate in a damages case has failed.  In fact, it may well be that Judge Alsop’s warning in [...]

Read more »

Share your thoughts...

What can IP valuators learn from the fashion wars?

Written by Randy on April 19, 2013 - 0 Comments
Categories: design patents, IP valuation research, Patent Litigation, Patents

As quoted in Forbes, Susan Scafidi, professor at Fordham Law School’s Fashion Law Institute, “… design patents exist and can protect ornamental aspects of clothing — if a company is willing to invest substantial time and money.” Bookmark on DeliciousDigg this postRecommend on Facebookshare via RedditShare with StumblersTweet about itSubscribe to the comments on this [...]

Read more »

Share your thoughts...

Myriad argued before the U.S. Supreme Court

Written by Randy on April 15, 2013 - 0 Comments
Categories: case law analysis, commercial litigation, IP valuation research, Patent Litigation, Patents, United States Patent and Trademark Office, USPTO

On 04/15/2013 the United States Supreme Court hears oral arguments in Molecular Pathology v. Myriad Genetics. For background information, see previous IP Value Wire coverage. Bookmark on DeliciousDigg this postRecommend on Facebookshare via RedditShare with StumblersTweet about itSubscribe to the comments on this post

Read more »

Share your thoughts...

Court says lone settlement agreement cannot support plaintiff’s damages theory

Written by Randy on April 10, 2013 - 0 Comments
Categories: case law analysis, commercial litigation, damages, Daubert hearing, expert witness, IP valuation research, IP value comparables & research, licensing, Patent Litigation, royalties-reasonable

After AVM sued Intel for infringing on one of its patents, its expert established reasonable royalty damages between $150 million and $300 million “or more.” Intel filed a Daubert motion to exclude the testimony. Earlier, a federal court stated that it was inclined to rule in Intel’s favor but wanted to hear from the expert in person [...]

Read more »

Share your thoughts...

Details of the lawsuit-settling Dupont and Monsanto cross-license agreement released

Written by Randy on April 3, 2013 - 0 Comments
Categories: case law analysis, commercial litigation, infringement lawsuits, IP value comparables & research, licensing, Patent Litigation, royalties-reasonable, royalty

On March 26, DuPont and Monsanto announced financial terms of the technology cross-licensing agreements that also settled their patent and antitrust lawsuits relating to Monsanto’s Round-Up® resistant soybean seeds. Bookmark on DeliciousDigg this postRecommend on Facebookshare via RedditShare with StumblersTweet about itSubscribe to the comments on this post

Read more »

Share your thoughts...

Next Page »

  • Recent Posts

    • Rovio announces it will begin publishing games developed by third parties
    • Blogger tries humor to implore the courts come to grips with software patents
    • Michael Jordan’s infringement lawsuit tarnished the reputation of defendant, so new suit says
    • U.S. Supreme Court decides for Monsanto and its patent on weed-killer resistant soybean seeds
    • Disney’s attempt to trademark a cultural holiday runs into social media wall
  • Blogroll

    • Ian McClure’s IP Prospective
    • Intellectual Property Watch
    • IP Think Tank’s Think IP Strategy
    • IPCloseUp
    • IPLawAlert
    • IPMetrics blog
    • Law 360’s Intellectual Property Law
    • Mike Moberly's Business IP blog
    • Mission Intangible!
    • Patently-O
  • Enter your email address:

  • Categories

    • bankruptcy
    • best practices
    • brand value
    • business combinations
    • case law analysis
    • Chief Intellectual Property Officer
    • CLE
    • commercial litigation
    • copyright values
    • CPE opportunities
    • customer relationships value
    • damages
    • damages and lost profits valuations
    • Daubert hearing
    • design
    • design patents
    • early stage IP
    • EPO
    • expert witness
    • fair value accounting
    • financial reporting for IP
    • infringement lawsuits
    • intangible property
    • intellectual property
    • intellectual property M&A
    • investing in IP
    • ip monetization
    • IP ownership
    • IP strategy
    • IP valuation research
    • IP value comparables & research
    • ITC
    • legislation
    • licensing
    • Patent Litigation
    • Patents
    • policy
    • purchase price allocation
    • relief-from-royalty
    • reputation
    • royalties-reasonable
    • royalty
    • security
    • software patent
    • technology transfer
    • trade dress
    • Trade Secrets
    • trademark
    • trademark infringement
    • transfer pricing
    • Uncategorized
    • United States Patent and Trademark Office
    • USPTO
  • Blogroll

    • Ian McClure’s IP Prospective
    • Intellectual Property Watch
    • IP Think Tank’s Think IP Strategy
    • IPCloseUp
    • IPLawAlert
    • IPMetrics blog
    • Law 360’s Intellectual Property Law
    • Mike Moberly's Business IP blog
    • Mission Intangible!
    • Patently-O

Admin Login

Powered by frugal


Copyright © 2013 BVR's IP Management & Valuation Wire